Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M-L Cerrina
Phase II Study of Nitrosourea Fotemustine as Single-Drug Chemotherapy in Poor-Prognosis Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer
BioScience Trends
Biochemistry
Health
Medicine
Genetics
Molecular Biology
Phase II Study of Gemcitabine Plus Oxaliplatin as First-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Phase II Study of ACNU in Non-Small-Cell Lung Cancer: EORTC Study 08872
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Low Level of 5-Hydroxymethylcytosine Predicts Poor Prognosis in Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Nociceptin Receptor Is Overexpressed in Non-Small Cell Lung Cancer and Predicts Poor Prognosis
Frontiers in Oncology
Cancer Research
Oncology
Single Agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study
Research in Oncology
Overexpression of lncRNA EGFR‑AS1 Is Associated With a Poor Prognosis and Promotes Chemotherapy Resistance in Non‑small Cell Lung Cancer
International Journal of Oncology
Cancer Research
Oncology
A Phase II Study of High Dose Epirubicin in Unresectable Non Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
